story of the week
Efficacy of Three Neuroprotective Drugs in Secondary Progressive Multiple Sclerosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy of Three Neuroprotective Drugs in Secondary Progressive Multiple Sclerosis (MS-SMART): A Phase 2b, Multiarm, Double-Blind, Randomised Placebo-Controlled Trial
Lancet Neurol 2020 Mar 01;19(3)214-225, J Chataway, F De Angelis, P Connick, RA Parker, D Plantone, A Doshi, N John, J Stutters, D MacManus, F Prados Carrasco, F Barkhof, S Ourselin, M Braisher, M Ross, G Cranswick, SH Pavitt, G Giovannoni, CA Gandini Wheeler-Kingshott, C Hawkins, B Sharrack, R Bastow, CJ Weir, N Stallard, S ChandranFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.